Cargando…

Cancer burden in China: a Bayesian approach

BACKGROUND: Cancer is a serious health issue in China, but accurate national counts for cancer incidence are not currently available. Knowledge of the cancer burden is necessary for national cancer control planning. In this study, national death survey data and cancer registration data were used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wanqing, Armstrong, Bruce K, Zheng, Rongshou, Zhang, Siwei, Yu, Xueqin, Clements, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850959/
https://www.ncbi.nlm.nih.gov/pubmed/24093796
http://dx.doi.org/10.1186/1471-2407-13-458
_version_ 1782294198764961792
author Chen, Wanqing
Armstrong, Bruce K
Zheng, Rongshou
Zhang, Siwei
Yu, Xueqin
Clements, Mark
author_facet Chen, Wanqing
Armstrong, Bruce K
Zheng, Rongshou
Zhang, Siwei
Yu, Xueqin
Clements, Mark
author_sort Chen, Wanqing
collection PubMed
description BACKGROUND: Cancer is a serious health issue in China, but accurate national counts for cancer incidence are not currently available. Knowledge of the cancer burden is necessary for national cancer control planning. In this study, national death survey data and cancer registration data were used to calculate the cancer burden in China using a Bayesian approach. METHODS: Cancer mortality and incidence rates for 2004–2005 were obtained from the National Cancer Registration database. The third National Death Survey (NDS), 2004–2005 database provided nationally representative cancer mortality rates. Bayesian modeling methods were used to estimate mortality to incidence (MI) ratios from the registry data and national incidence from the NDS for specific cancer types by age, sex and urban or rural location. RESULTS: The total estimated incident cancer cases in 2005 were 2,956,300 (1,762,000 males, 1,194,300 females). World age standardized incidence rates were 236.2 per 100,000 in males and 168.9 per 100,000 in females in urban areas and 203.7 per 100,000 and 121.8 per 100,000 in rural areas. CONCLUSIONS: MI ratios are useful for estimating national cancer incidence in the absence of representative incidence or survival data. Bayesian methods provide a flexible framework for smoothing rates and representing statistical uncertainty in the MI ratios. Expansion of China’s cancer registration network to be more representative of the country would improve the accuracy of cancer burden estimates.
format Online
Article
Text
id pubmed-3850959
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38509592013-12-13 Cancer burden in China: a Bayesian approach Chen, Wanqing Armstrong, Bruce K Zheng, Rongshou Zhang, Siwei Yu, Xueqin Clements, Mark BMC Cancer Research Article BACKGROUND: Cancer is a serious health issue in China, but accurate national counts for cancer incidence are not currently available. Knowledge of the cancer burden is necessary for national cancer control planning. In this study, national death survey data and cancer registration data were used to calculate the cancer burden in China using a Bayesian approach. METHODS: Cancer mortality and incidence rates for 2004–2005 were obtained from the National Cancer Registration database. The third National Death Survey (NDS), 2004–2005 database provided nationally representative cancer mortality rates. Bayesian modeling methods were used to estimate mortality to incidence (MI) ratios from the registry data and national incidence from the NDS for specific cancer types by age, sex and urban or rural location. RESULTS: The total estimated incident cancer cases in 2005 were 2,956,300 (1,762,000 males, 1,194,300 females). World age standardized incidence rates were 236.2 per 100,000 in males and 168.9 per 100,000 in females in urban areas and 203.7 per 100,000 and 121.8 per 100,000 in rural areas. CONCLUSIONS: MI ratios are useful for estimating national cancer incidence in the absence of representative incidence or survival data. Bayesian methods provide a flexible framework for smoothing rates and representing statistical uncertainty in the MI ratios. Expansion of China’s cancer registration network to be more representative of the country would improve the accuracy of cancer burden estimates. BioMed Central 2013-10-06 /pmc/articles/PMC3850959/ /pubmed/24093796 http://dx.doi.org/10.1186/1471-2407-13-458 Text en Copyright © 2013 Chen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chen, Wanqing
Armstrong, Bruce K
Zheng, Rongshou
Zhang, Siwei
Yu, Xueqin
Clements, Mark
Cancer burden in China: a Bayesian approach
title Cancer burden in China: a Bayesian approach
title_full Cancer burden in China: a Bayesian approach
title_fullStr Cancer burden in China: a Bayesian approach
title_full_unstemmed Cancer burden in China: a Bayesian approach
title_short Cancer burden in China: a Bayesian approach
title_sort cancer burden in china: a bayesian approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850959/
https://www.ncbi.nlm.nih.gov/pubmed/24093796
http://dx.doi.org/10.1186/1471-2407-13-458
work_keys_str_mv AT chenwanqing cancerburdeninchinaabayesianapproach
AT armstrongbrucek cancerburdeninchinaabayesianapproach
AT zhengrongshou cancerburdeninchinaabayesianapproach
AT zhangsiwei cancerburdeninchinaabayesianapproach
AT yuxueqin cancerburdeninchinaabayesianapproach
AT clementsmark cancerburdeninchinaabayesianapproach